Betahistine for residual dizziness after canalith repositioning in benign paroxysmal positional vertigo: a systematic review of randomized controlled trials

Audiologists and vestibular specialists managing post-CRM residual dizziness in BPPV patients should review this systematic review's pooled findings; if betahistine shows significant benefit, it may warrant a protocol update in collaboration with referring physicians.